Literature DB >> 26162691

Pathophysiology of mitochondrial disease causing epilepsy and status epilepticus.

Shamima Rahman1.   

Abstract

Epilepsy is part of the clinical phenotype in nearly 40% of children with mitochondrial disease, yet the underlying molecular mechanisms remain poorly understood. Energy depletion has been postulated as the cause of mitochondrial epilepsy, but if this were the case, then 100% of patients with mitochondrial disease would be expected to present with seizures. This review explores other potential disease mechanisms underlying mitochondrial epilepsy, including oxidative stress, impaired calcium homeostasis, immune dysfunction, and deficiency of vitamins, cofactors, reducing equivalents, and other metabolites. Different mechanisms are likely to predominate in different mitochondrial disorders, since mitochondrial function varies between neurons and astrocytes, between different types of neurons, and in different brain regions. Systematic studies in cell and animal models of mitochondrial disease are needed in order to develop effective therapies for mitochondrial epilepsy. This article is part of a Special Issue entitled "Status Epilepticus".
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcium homeostasis and signaling; Cerebral folate deficiency; Coenzyme Q(10); Epilepsy; Immune dysfunction; Mitochondrial disease; Neuronal energy depletion; Oxidative stress; Seizure; l-arginine

Mesh:

Year:  2015        PMID: 26162691     DOI: 10.1016/j.yebeh.2015.05.003

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  17 in total

1.  A Metabolic Paradigm for Epilepsy.

Authors:  Manisha Patel
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

2.  The Study of Genetic Susceptibility and Mitochondrial Dysfunction in Mesial Temporal Lobe Epilepsy.

Authors:  Haiyan Yang; Fei Yin; Siyi Gan; Zou Pan; Ting Xiao; Miriam Kessi; Zhuangyi Yang; Victor Wei Zhang; Liwen Wu
Journal:  Mol Neurobiol       Date:  2020-07-06       Impact factor: 5.590

3.  IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation.

Authors:  Armin Mortazavi; Islam Fayed; Muzna Bachani; Tyrone Dowdy; Jahandar Jahanipour; Anas Khan; Jemima Owotade; Stuart Walbridge; Sara K Inati; Joseph Steiner; Jing Wu; Mark Gilbert; Chun Zhang Yang; Mioara Larion; Dragan Maric; Alexander Ksendzovsky; Kareem A Zaghloul
Journal:  Neuro Oncol       Date:  2022-09-01       Impact factor: 13.029

4.  The Cyclic Vomiting Syndrome Threshold: A Framework for Understanding Pathogenesis and Predicting Successful Treatments.

Authors:  David J Levinthal
Journal:  Clin Transl Gastroenterol       Date:  2016-10-27       Impact factor: 4.488

Review 5.  Understanding the Epilepsy in POLG Related Disease.

Authors:  Omar Hikmat; Tom Eichele; Charalampos Tzoulis; Laurence A Bindoff
Journal:  Int J Mol Sci       Date:  2017-08-24       Impact factor: 5.923

6.  Proenkephalin Derived Peptides Are Involved in the Modulation of Mitochondrial Respiratory Control During Epileptogenesis.

Authors:  Johannes Burtscher; Camilla Bean; Luca Zangrandi; Iwona Kmiec; Alexandra Agostinho; Luca Scorrano; Erich Gnaiger; Christoph Schwarzer
Journal:  Front Mol Neurosci       Date:  2018-09-25       Impact factor: 5.639

Review 7.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

8.  Clinical and Molecular Characteristics in 100 Chinese Pediatric Patients with m.3243A>G Mutation in Mitochondrial DNA.

Authors:  Chang-Yu Xia; Yu Liu; Hui Liu; Yan-Chun Zhang; Yi-Nan Ma; Yu Qi
Journal:  Chin Med J (Engl)       Date:  2016-08-20       Impact factor: 2.628

9.  Recent perspectives of pediatric mitochondrial diseases.

Authors:  Junhua Cao; Hongwei Wu; Zhenguang Li
Journal:  Exp Ther Med       Date:  2017-10-27       Impact factor: 2.447

10.  Spectrum of movement disorders and neurotransmitter abnormalities in paediatric POLG disease.

Authors:  A Papandreou; S Rahman; C Fratter; J Ng; E Meyer; L J Carr; M Champion; A Clarke; P Gissen; C Hemingway; N Hussain; S Jayawant; M D King; B J Lynch; L Mewasingh; J Patel; P Prabhakar; V Neergheen; S Pope; S J R Heales; J Poulton; Manju A Kurian
Journal:  J Inherit Metab Dis       Date:  2018-08-30       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.